Laird Norton Trust Company, LLC Cardiol Therapeutics Inc. Transaction History

Laird Norton Trust Company, LLC

  • $621 Million
  • Q1 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.76 - $1.19 $29,391 - $46,020
38,673 Added 63.06%
100,000 $90,000
Q1 2023

May 15, 2023
BUY
$0.47 - $0.81 $28,823 - $49,674
61,327 New
61,327 $30,000

Others Institutions Holding CRDL

# of Institutions
45
Shares Held
7.84M
Call Options Held
25.9K
Put Options Held
1.7K
View Full List

About Cardiol Therapeutics Inc.

CRDL Quotes by TradingView
  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $92.3M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Laird Norton Trust Company, LLC Portfolio

Follow Laird Norton Trust Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laird Norton Trust Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email